Edwards Lifesciences (EW) - Stock & Dividends

Exchange: USA Stocks • Country: United States • Currency: USD • Type: Common Stock • ISIN: US28176E1082

(NYSE:EW Stock) Edwards Lifesciences Corporation provides products and technologies for structural heart disease and critical care monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of aortic heart valves under the Edwards SAPIEN family of valves system; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases under the PASCAL PRECISION and Cardioband names. The company also provides surgical structural heart solutions, such as aortic surgical valve under the INSPIRIS name; INSPIRIS RESILLA aortic valve, which offers RESILIA tissue and VFit technology; KONECT RESILIA, a pre-assembled tissue valves conduit for complex combined procedures; and MITRIS RESILIA valve. In addition, it offers critical care solutions, including hemodynamic monitoring systems to measure a patient's heart function and fluid status in surgical and intensive care settings under the FloTrac, Acumen IQ sensors, ClearSight, Acumen IQ cuffs, and ForeSight names; HemoSphere, a monitoring platform that displays physiological information; and Acumen Hypotension Prediction Index software that alerts clinicians in advance of a patient developing dangerously low blood pressure. The company distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California. Web URL: https://www.edwards.com

Drawdown (Underwater) Chart

Drawdown / Underwater Chart for Edwards Lifesciences (EW) - Stock & Dividends

EW Stock Overview

Market Cap in USD 51,772m
Sector Healthcare
Industry Medical Devices
GiC SubIndustry Health Care Equipment
TER 0.00%
IPO / Inception 2000-03-27

EW Stock Ratings

Fundamental 5.43
Dividend -
Growth 5y 2.03
Rel. Performance vs Sector -0.08
Analysts 3.74
Fair Price Total Ret. 79.55
Fair Price DCF 26.38

EW Dividends

Yield 12m 0.00%
Yield on Cost 5y 0.00%
Dividends CAGR 5y 0.00%
Payout Consistency 0.0%

EW Growth Ratios

Growth 12m 15.02%
Growth Correlation 12m -30%
Growth Correlation 3m 60%
CAGR 5y 8.59%
CAGR / Mean Drawdown 0.49
Sharpe Ratio 12m 0.34
Alpha vs SP500 12m -14.85
Beta vs SP500 5y weekly 1.17
CAPM 8.46%
Average Daily Range 2m 2.58%
Regime Oscillator 84.72
Volatility GJR Garch 1y 27.85%
Price / SMA 50 12.27%
Price / SMA 200 11.15%
Current Volume 3235.8k
Average Volume 20d 4922.4k
What is the price of EW stocks?
As of February 21, 2024, the stock is trading at USD 86.90 with a total of 3,235,818 shares traded.
Over the past week, the price has changed by +0.74%, over one month by +16.94%, over three months by +29.33% and over the past year by +15.02%.
Why is EW stock down?
Check with which Index or Commodity EW has the highest Correlation, do they have a common driver?
Review the Fundamentals to find weaknesses (Debt, low returns). Check the Performance of the Peer-Group to find out, if the entire sector is under pressure.
Period Return EW Return S&P 500
1 Month 16.94% 2.97%
3 Months 29.33% 9.80%
12 Months 15.02% 26.37%
What is the forecast for EW stock price target?
According to ValueRays Forecast Model, EW Edwards Lifesciences will be worth about 87.6 in February 2025.
Issuer Forecast Upside
Wallstreet Target Price 91.3 5.1%
Analysts Target Price 91.3 5.1%
ValueRay Target Price 87.6 0.7%